"While this may explain drug-induced Parkinsonism, it is likely that other factors may contribute to PD pathogenesis," they wrote. One case series found, for instance, that patients who initially ...

A leukemia drug may have cleared another hurdle as a potential treatment for Parkinson's disease. But critics say it's still not clear whether the drug, nilotinib (brand name Tasigna), is truly ...

Differentiating Parkinson’s disease dopamine neurons from induced pluripotent stem cells (iPSCs) obtained from a patient with the condition, they treated the neurons with M324.

University of Pennsylvania. (2019, June 21). A new drug target for chemically induced Parkinson's disease. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2019 / 06 ...

Movement disorders lead to either increased or slow movement affecting actions you choose to make. There are several types of ...

Parkinson's Disease: Nicotine Reduces Levodopa-induced Dyskinesias. ScienceDaily . Retrieved June 4, 2025 from www.sciencedaily.com / releases / 2007 / 10 / 071024093555.htm ...

Researchers have found that a drug used to treat the symptoms of Parkinson’s disease may be effective at treating metastatic breast cancer and the brain metastases that can often result. The ...

Mice were given agents that induced Parkinson’s-like pathologies in their brains. Either four or eight days later, depending on the cohort, the researchers began giving them once-daily doses of ...

This treatment also reduced the effect of drug-induced rigidity and tremor. Finally, they showed that the approach also reversed “motor impairment” in a mouse model of Parkinson’s disease ...

Several drugs, including entacapone, contain metal-binding catechol groups, suggesting that this mechanism could be a more common pathway for drug-induced microbiome alterations.

Parkinson’s drug, entacapone, induces iron deficiency, which alters the gut microbiome and triggers the growth of potentially harmful bacteria like E. coli, reports a new study.The findings mean that ...

More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson's disease. We use cookies to enhance your experience.